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Abstract 
Psychological symptoms are highly prevalent in people requiring palliative care. They are 
much more challenging to elicit and more controversy exists about what is normal and what 
might require intervention than physical symptoms. There are significant issues in 
determining what is normal and what is not. Sadness, distress, anxiety and depression can 
co-exist and require careful assessment. 
 
Management of psychological symptoms and conditions can broadly be considered in terms 
of non-pharmacological and pharmacological therapies; “the talking and the drug 
therapies.” These are not mutually exclusive and for people with limited energy, failing 
cognition and limited time some pragmatic decisions may be necessary. To be distressed 
and immobilised by emotion is not normal. Depression is not a normal part of dying. There 
should be discussion about the nature of psychological issues and conditions, explanation of 
common somatic symptoms and a plan for intervention and support. 
 










Symptom control is a significant part of the healthcare interventions provided by clinicians 
for people facing the end of their lives. Physical symptoms are generally well recognised and 
have a considerable prevalence (e.g. lack of energy (73.4%), pain (63.1%), nausea (44.7%), 
lack of appetite (44.5%), constipation (33.6%), cough (29.4%) and shortness of breath 
(22.9%)).(Portnoy, Thaler et al. 1994) Psychological symptoms are much more challenging to 
elicit and more controversy exists about what is normal and what might require 
intervention. Symptoms such as anxiety and depression may not be as easily acknowledged, 
diagnosed or treated by patients, carers or healthcare providers.(Derogatis, Morrow et al. 
1983, Razavi, Delvaux et al. 1990, Barraclough 1997, Dein 2000, Henderson, Andrews et al. 
2000, Gilbody, House et al. 2001) For many the label of a “psychiatric” or “mental health” 
issue carries a strong stigma. Some would see serious risks associated with “unnecessary 
pathologising” what are possibly normal reactions.(Parker, Fletcher et al.) This can inhibit 
full assessment and the consideration and implementation of appropriate interventions to 
provide relief. 
What is normal – sadness, distress, anxiety and depression 
The diagnosis of an incurable illness is associated with an expected emotional response to 
the loss of well-being and to a potentially limited and altered future. Sadness, tearfulness, 
altered sleep and change in appetite and eating habits are a normal response to receipt of 
this information and the impending loss it conveys.(Zisook and Shear 2009) These symptoms 
constitute a grief reaction.(Kübler-Ross 1969, Periyakoil 2001, Grunfeld, Coyle et al. 2004) 
The symptoms of grief and sadness, as responses to such a situation, can be seen to be on a 
continuum with those of an anxiety and major depressive illness. Depression is not 
necessarily the inevitable response to such a situation. This raises the dilemma of defining 
thresholds(Chochinov, Wilson et al. 1994, Robinson and Crawford 2005) at which a 
diagnosis is made and what might be considered to be the “normal” reaction to considering 
the possible end of one’s own life. Emotions to death and dying and reactions to such 
information is modified by personal beliefs and cultural factors, particularly relating to what 
a person might believe occurs after they die. There are cross cultural and historical attitudes 
to such complex issues including belief in an after-life with perhaps heaven and hell, to a 
nihilism or sense of nothingness,. Kübler-Ross introduced the concept of different types of 
depression – a reactive and a preparatory depression – the latter being seen as a normal 
part of the dying process and something that should not be interrupted.(Kübler-Ross 1969) 
She believed that “an understanding person will have no difficulty in eliciting the cause [of 
the depression]”. This is not as easy as she has suggested but may help to explain why some 
clinicians feel inhibited or may fail to intervene in distress, anxiety, depression or even to 
assess systematically for psychological symptoms. 
 
The person experience 
It is always useful for healthcare providers to try to put themselves in the shoes of their 
patients or clients. It is all too easy to forget how foreign the environments are that we work 
within and how vulnerable our patients are. Not only are they being given bad news and 
potentially life-threatening information but there are larger issues to consider. Not only are 
people trying to understand the problem and ask the obvious questions about what might 
be done to cure, control or modify the process, but there are physical symptoms to manage 
and changes in body function. There are multiple demands for healthcare appointments and 
relationships to navigate with multiple providers. The need for information, clear 
communication and a sense of some control in what feels like the uncontrollable all are 
aspects of the experience for most. 
 
It is not surprising that there will be impacts on work and leisure. There will be disruption of 
home, social and financial arrangements. There are going to be changing roles and functions 
within the family. And in all of this most will be dealing with the understandable fear of loss 
of role, function, purpose and fear of death. And most would wish to maintain or find a new 
sense of meaning and purpose in life. 
 
Distress 
Psychological issues may present in many ways. Some people may express distress, 
depression or anxiety in terms of unrelieved physical symptoms rather than emotion. It may 
be that there is only limited mild intermittent distress, or it may a severe persistent distress 
that can become an overwhelming anxiety.(National Comprehensive Cancer Network 2003) 
And there are questions about whether anxiety leads to depression or vice versa. And it is 
reasonable to consider that these issues are not simply binary, i.e. both can co-exist and 
feed into the expression of psychological distress and vary over time. Exploring a person’s 
experience of their illness, understanding the context and meaning ascribed to that illness 
and the physical, social, emotional and spiritual influences and components of their distress 
are all vital to more fully assess and understand the person’s experience.(Clayton, Hancock 
et al. 2007) 
 
Demoralisation 
Within palliative care literature, demoralisation as a syndrome has been proposed by 
Kissane et al(Kissane, Clarke et al. 2001) as having core features of hopelessness, loss of 
meaning, and existential distress. It is believed that this syndrome can be differentiated 
from depression and is recognizable in people facing the end of their lives.  It is associated 
with chronic medical illness, disability, bodily disfigurement, fear of loss of dignity, social 
isolation, and feelings of greater dependency on others or the perception of being a burden. 
 
Because of a sense of helplessness, those with the syndrome are thought to progress to a 
desire to die or to commit suicide. Treatment is aimed at relieving or alleviating the distress 
caused by this syndrome. The Cambridge dictionary(Cambridge University Press 2018) 
describes demoralisation as “having lost your confidence, enthusiasm, and hope.” And also 
suggests feelings of sadness and unhappiness. Some alternative words and phrases have 
included “being down in the dumps, doleful, downhearted, miserable, morose and feeling 
wretched.” These are powerful words and feelings. 
Anxiety 
Anxiety is a feeling of worry, nervousness, or unease about something with an uncertain 
outcome often with an associated strong concern that something unpleasant might 
happen.(CareSearch 2017) For people facing the end of their lives it would seem entirely 
reasonable that there is a fear or threat of separation and loss. It is common to hear people 
voice fears not only about death, but also about the dying process, the manner of dying, the 
course of the illness, and the impact on their family. It is important to ask about suicidal 
thoughts or impulses in a patient experiencing significant anxiety or depressive 
symptoms.(Hudson, Schofield et al. 2006) Anxiety can accompany a depressive disorder. 
 
The challenge is to be able to broach these difficult but important conversations. This 
requires a willingness to ask questions, to make connection, to have advanced 
communication skills and be willing to listen. Some possible opening questions might be, 
‘What do you feel about everything that is happening to you?’; ‘You seem 
(upset/anxious/depressed) today. Would you like to talk about how things are going?’ 
 
A full assessment requires specific questions about anxiety, depression and likely symptoms. 
An exploration of physical symptoms such as palpitations, nausea, dizziness, shortness of 
breath, trembling, sweating and diarrhoea is useful. Psychological symptoms may include 
feelings of apprehension, fear and dread. You should also consider treatment-related 
factors, drug-induced anxiety, drug withdrawal including alcohol, tobacco, other drugs and 
disease-related factors, such as poor control of pain, nausea, dyspnoea and 
hypoxia.(Palliative Care Expert Group:, Moulds R et al. 2016) 
 
It is important to assess for a depressive disorder as this may be the underlying condition 
when anxiety is severe, and it does not respond to supportive measures. 
 
Depression 
Depression is a major health issue in Australia.(Wilhelm, Mitchell et al. 2003) There is a 
growing body of research about depression in palliative care populations and concern that it 
is a difficult and not particularly well-managed problem. This may relate to the inherent 
nature of depression but is possibly compounded by the difficulties of assessment and 
management in palliative populations, a group of people with many physical symptoms and 
the added burden of the existential issues associated with anticipating the end of life. 
 
Depression has a significant and often unseen impact on the well-being and quality of 
life(Grassi, Indelli et al. 1996, Goldney, Fisher et al. 2000, Ruo, Rumsfeld et al. 2003, Smith, 
Gomm et al. 2003) of the people it affects and on those around them. However, the 
construct and definition of depression is difficult. It is poorly understood. The general public 
and even health professionals may have quite different and divergent concepts, 
understandings and beliefs about what depression is.(Ng, Crawford et al. 2013, Ng, 
Crawford et al. 2014, Ng, Crawford et al. 2014) The general public may consider crying, 
feeling sad, being melancholic or feeling “upset” or “down and blue” to be depression. 
Palliative care professionals are often untrained in psychological health assessment and 
management. They are likely to have varied and possibly inaccurate concepts about 
psychological illness. A mental health professional diagnosis of a major depressive illness 
requires a constellation of specific symptoms that may include feelings of sadness and 
feeling “down and blue” that are pervasive and persistent.(World Health Organization 1993, 
American Psychiatric Association 2013) Symptoms are on a spectrum of severity and can 
extend to a psychotic illness with loss of contact with reality and with loss of hope for the 
present or the future. Even the diagnostic systems proposed by specialist psychological 
authorities vary in the symptom constructs that are described to make a diagnosis, and the 
instructions and advice offered may be difficult to interpret and implement. 
 
Depression is a prevalent problem in our society.(Chochinov, Wilson et al. 1994, Hotopf, 
Chidgey et al. 2002, Lloyd-Williams and Riddleston 2002, Durkin, Kearney et al. 2003, Meyer, 
Sinnot et al. 2003) Depression is poorly recognised and poorly treated(Lloyd-Williams 1999, 
Wilson, Chochinov et al. 2000, Durkin, Kearney et al. 2003, Lloyd-Williams, Dennis et al. 
2003, Lloyd-Williams, Spiller et al. 2003) within palliative care patients, causing increased 
suffering and hardship for these patients and their carers and families. Physical symptom 
control can be much more difficult to achieve in these patients.(Dinan 1999) Carers’ ability 
to support their depressed family member or friend may be diminished, at a time when 
there may be very little pleasure remaining in their lives. Interaction with and assistance 
from health care providers can be impeded, resulting in poorer health outcomes.(Spiegel 
1996, DiMatteo, Lepper et al. 2000, Passik, Kirsh et al. 2002, Kelly, Burnett et al. 2003, Lin, 
Katon et al. 2003) Depressed patients are less likely to attend appointments.(DiMatteo, 
Lepper et al. 2000) They are likely to feel bad about themselves and to make people around 
them feel uncomfortable, further perpetuating their isolation. They are more likely to be 
seen as “bad” or “difficult” patients, further reinforcing these negative feelings. 
 
In Australia, the current one month prevalence of major depression in the general 
population is 3-5%.(Wilhelm, Mitchell et al. 2003) This is similar to the reported prevalence 
in the United States of America and the United Kingdom.(Wilhelm, Mitchell et al. 2003) 
Depression is reported to be more common in the unemployed, smokers, and those having 
a medical condition,(Breitbart, Bruera et al. 1995, Block 2000) as well as being in mid-
life,(Fredman, Weissman et al. 1988, Sorenson, Rutter et al. 1991, Blazer, Kessler et al. 
1994) those previously married and in females.(Goldberg and Huxley 1992, Weissman, 
Bland et al. 1996) Depression is predicted to be one of the leading contributors to the 
burden of disease into the future.(Murray and Lopez 1996) 
 
In the medically unwell, the assessment of depression is more problematic, and the 
prevalence is much more difficult to determine. In a systematic review of the prevalence of 
depression in patients with advanced disease, particularly advanced cancer and amongst 
mixed hospice populations, i.e. palliative care populations, Hotopf et al(Hotopf, Chidgey et 
al. 2002) found that depression was a common problem; however, the quality of research 
was poor. The prevalence of depression varied between 1% and 50%. This variation is likely 
to be because of small sample size, and large attrition and exclusion rates, due to 
deteriorating physical and mental function and death, and different definitions for making a 
diagnosis of depression. Many studies provided limited information about participants 
including demographic and clinical details and failed to provide “any data on the extent or 
severity of the participants’ disease and their survival.” The generally agreed prevalence of 
depression in the medically unwell and in palliative care populations is 25%.(Barraclough 
1999) Depression in this population is greater in the young(Blazer, Kessler et al. 1994) and in 
some particular diseases (e.g. carcinoma of the pancreas).(Holland, Korzun et al. 1986) 
There have been studies of the interaction between asthma and diabetes with depression, 
showing that with increased physical symptoms there is also an increase in 
depression.(Goldney, Ruffin et al. 2003, Goldney, Phillips et al. 2004) 
 
There are accepted systems for classifying the symptoms and signs required to make a 
diagnosis of depression.(World Health Organization 1993, American Psychiatric Association 
2013) There is however no single universally agreed system to confirm such a diagnosis and 
no one objective measure. The “gold standard” for making a diagnosis remains a systematic, 
structured clinical interview followed by the judgement of a mental health professional. The 
two widely accepted classifications of mental illnesses are the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) of the American Psychiatric Association(American 
Psychiatric Association 2013) and the International Classification of Diseases (ICD) 
developed by the World Health Organisation.(World Health Organization 1993) Many of the 
symptoms that might be considered may be on the continuum from normal variation to a 
clinical disease or condition. There is also possible overlap of symptom criteria with other 
known physical and psychological diseases and conditions. The diagnostic process requires 
the patient to have the physical, mental and psychological capability to participate. There 
are clearly potential and real barriers to the assessment and diagnosis of depression, 
particularly in terminal illness. See Table 1. 
 
A DSM-5 diagnosis of a major depressive episode requires that five symptoms, which may 
include both psychological and somatic symptoms, be present during the same period and 
that one of these is either depressed affect or anhedonia.(American Psychiatric Association 
2013) DSM-5 diagnostic criteria for a major depressive episode include somatic symptoms 
that are common amongst medically ill patients, such as fatigue, change in weight, altered 
sleep patterns and concentration. These somatic symptoms of depression may overlap with 
the symptoms of many medical illnesses. DSM-5 instructs doctors to exclude potential 
somatic symptoms of depression “when they are clearly attributable to another medical 
condition.”(American Psychiatric Association 2013) But this advice creates practical 
problems.(Peveler, Carson et al. 2006) For a population with a large number of “somatic 
symptoms,” this instruction is not as easily translated into practice as might be suggested. It 
is often impossible to determine the aetiology of symptoms. There is concern that including 
somatic symptoms of unknown aetiology may lead to over-diagnosing 
depression.(Ouslander 1982, Endicott 1984, Rapp and Vrana 1989, Kalichman, Rompa et al. 
2000) Alternatives to DSM-5 and ICD-10 classifications of depression have been proposed to 
differentiate depression from symptoms of a wide range of medical conditions, including 
cancer,(Endicott 1984) Parkinson’s Disease,(Marsh, McDonald et al. 2006) dementia,(Vida, 
Des Rosiers et al. 1994) chronic pain(Wilson, Mikail et al. 2001) and generally for the 
elderly.(Rapp and Vrana 1989, Gallo and Rabins 1999) They include three approaches: 
“aetiological” (case-by-case or blanket exclusion from diagnostic criteria of symptoms 
judged likely to be due to medical illness or ageing); “inclusive” (inclusion of all symptoms 
regardless of aetiology); and “substitutive” (substitution of additional psychological 
symptoms for most or all somatic symptoms).(Endicott 1984, Cohen-Cole and Stoudemire 
1987, Rapp and Vrana 1989, Kathol, Mutgi et al. 1990, Chochinov, Wilson et al. 1994) 
Judging whether a symptom is “clearly and fully accounted for” by the patient’s medical 
condition may be impractical. 
 
Ellis et al(Ellis, Robinson et al. 2006) compared the two extreme approaches that do not 
require this judgement, i.e. the inclusion of somatic symptoms regardless of aetiology (i.e. 
the DSM-5 guideline is ignored) and the exclusion of somatic symptoms which might be 
caused by the patient’s medical condition or ageing. Somatic symptoms regardless of their 
aetiology did not adversely affect the identification of patients who showed evidence of 
psychological distress warranting follow-up. In contrast, the exclusion of somatic symptoms 
potentially due to disease or ageing led to under-recognition of psychological distress.(Ellis, 
Robinson et al. 2006) Suggestions that somatic symptoms be excluded or substituted when 
assessing older and medically ill adults(Yesavage, Brink et al. 1982-1983, Bukberg, Penman 
et al. 1984, Rapp and Vrana 1989) were not supported. Whether somatic symptoms should 
be included, treated in a specific way or be excluded is still unclear and ultimately the 
decision must be left to the clinician and the individual situation. 
 
There are barriers to effective management of depression in palliative care: recognition, 
diagnostic and treatment barriers related to patients, clinicians and health care 
systems.(Goldman, Nielsen et al. 1999) Patients create an important barrier to the 
recognition of depression by their failure to disclose psychological distress.(Hinton 1994) 
Reasons may include a belief that talk about emotions is a waste of doctors’ time,(Maguire 
1985) that they are responsible for their own distress,(Maguire and Howell 1995) that 
depression is too common to be noteworthy,(Endicott 1984) and patient 
“stoicism”.(Endicott 1984) Indeed, patients may actively deny their psychological distress in 
order to avoid the stigma associated with psychological disorders, because they believe 
depression is a sign of weakness, to avoid causing additional worry to their families, or 
because they fear being seen as ungrateful for the efforts of their family and 
clinicians.(Endicott 1984) Patient disclosure is also influenced by clinicians’ conscious or 
unconscious use of tactics that limit the expression of emotional distress.(Maguire 1985) 
 
Clinicians also directly contribute several barriers to the recognition and diagnosis of 
depression. Clinicians may have low motivation to identify patients with depression.(Wilson, 
Chochinov et al. 2000) Depression can be difficult to detect accurately. It is a syndromic 
disorder: no biological markers can be used to identify it. Diagnosis relies on emotions, 
behaviours, and cognitions that overlap those reported by patients with other psychological 
disorders and patients with no psychological disorder. As a result, it is known that 
symptoms of depression may not be recognised accurately by day care staff,(McIntyre 1982) 
nurses,(McDonald, Passik et al. 1999, Passik, Donaghy et al. 2000, Meyer, Sinnot et al. 2003, 
Pautex, Berger et al. 2003) or doctors(Passik, Dugan et al. 1998, Passik, Donaghy et al. 2000, 
Durkin, Kearney et al. 2003, Pautex, Berger et al. 2003) who do not have specialist mental 
health training. Nurses recruited to palliative care services are rarely required to have 
mental health training and their continuing education generally fails to focus on these 
issues.(Lloyd-Williams and Payne 2003) 
 
Assessment 
A careful and considered history is always the first step in assessment.(Butow, Price et al. 
2015) The clinician should not be frightened of asking difficult questions. Not exploring a 
situation fully will lead to misunderstandings, assumptions and ultimately poor 
management. A diagnosis of major depression is based on having a depressed mood that 
cannot be lightened, loss of pleasure or interest, even within the limitations of the illness, 
an excessive feeling of being a burden to others, accompanied by a sense of worthlessness 
or low self-esteem, of fearfulness and/or anxiety  and avoiding others or withdrawal. 
There may be brooding or excessive guilt and/or remorse, a pervasive sense of hopelessness 
or helplessness, a persistent desire for death, or suicidal ideation with prominent and 
persistent insomnia and excessive irritability. 
 
Asking a person about their mood and exploring their thoughts including specifically asking 
about suicidal ideation or intent are not inherently dangerous. Indeed, it is indefensible to 
avoid these issues. It is unreasonable to fear that raising these issues might “give the person 
ideas.” This is not true. It is important however to explore the person’s thoughts about 
death and desire to actively end their life, the degree of planning, and access to means and 
intent to die.(Hudson, Schofield et al. 2006) Individual jurisdictions will have different 
thresholds and legal requirements for clinicians to ensure a person’s safety. To deprive a 
person of their liberty is a serious responsibility but at times this may be indicated and even 
more challenging when the person in consideration has a serious and potentially life-limiting 
illness. 
 
There are many questionnaires and screening tools that have been proposed to assist in 
making the diagnosis of a psychological disorder or condition.(Beck and Beck 1972, 
Chochinov, Wilson et al. 1997, Kramer 1999, Hickie, Davenport et al. 2001, Lloyd-Williams 
2001, Akizuki, Akechi et al. 2003, Arroll, Khin et al. 2003, Crawford and Robinson 2008) The 
gold standard is a structured clinical interview. Commonly used screening instruments may 
only be uni-dimensional considering “anxiety” as a single concept or “depression” or 
“depressed affect” such as using a visual analogue scale. That anxiety and depression are 
commonly co-existent is perhaps evidenced by the popularity of the Hospital Anxiety and 
Depression Scale (HADS) that is commonly used in clinical and research practice.(Kramer 
1999) 
 
The impact of treatment-related factors, drug-induced depression, drug withdrawal 
including alcohol, tobacco, other drugs(Passik and Theobald 2000) and disease-related 
factors, severe uncontrolled symptoms, or fear of symptoms such as pain should be part of 
the assessment. Important factors can include a past personal or family history of suicide 
attempt, cognitive problems (e.g. delirium) and any psychotic symptoms (e.g. hallucinations, 
delusions). An important part of the assessment should also include the person’s level of 
isolation and social and family support. 
 
Management 
Management of psychological symptoms and conditions can broadly be considered in terms 
of non-pharmacological and pharmacological therapies; “the talking and the drug 
therapies.” These are not mutually exclusive and for people with limited energy, failing 
cognition and limited time some pragmatic decisions may be necessary. 
 
The power of the clinician’s and the clinical team’s therapeutic relationship should never be 
under-estimated.(Marziali and Alexander 1991) To provide clear information and 
explanation of what is happening physically and psychologically can be reassuring for many 
to assist in coping with the personal and social impact of disease. Supportive counselling 
and just being willing to exploring the patient's distress, fears and concerns and to promote 
a realistic hope should not be minimised. Dealing with physical symptoms and trying to 
address social and financial concerns can offer significant reduction of distress. Promoting 
communication with and support from others and by involving family and carers in care of 
the patient are useful strategies. Helping people to remember and gather the emotional 
resources that have sustained them through their lives before this crisis is a useful strategy 
for many. These are in essence attempts to try to reframe the situation and to consider 
strategies that assist in finding meaning and purpose. 
 
Cognitive and other behavioural therapies can provide benefit(Coull and Morris 2011) but 
may not be readily accessible or people may not have sufficient energy, time and clear 
cognition to participate. Some of the nurturing therapies so well-known in hospice care can 
provide a place of safety and relief as well. Life review and making meaning, whether in 
formal Dignity therapy,(Chochinov 2002) structured or informal biography services or even 
reviewing the family photographs may all be useful. Therapies to induce relaxation and 
some sense of peace should be considered. Some gain benefit with massage, aromatherapy, 
visualisation and music therapies.(Hilliard 2001, Krout 2001, Demmer 2004, Kyle 2006, Ernst 
2009) 
 
Medication to moderate symptoms and to improve mood should be considered and if 
appropriate introduced early. Antidepressants have delay in maximum onset of therapeutic 
benefit. Many people are commenced on such medications when there is insufficient time 
to gain real and meaningful benefit.(Lloyd-Williams, Friedman et al. 1999) There is evidence 
that anything other than very short-term use of benzodiazepines is a useful strategy for the 
longer-term management of anxiety.(Palliative Care Expert Group:, Moulds R et al. 2016) 
Benzodiazepine medications with very short half-lives are particularly problematic 
particularly at the end of life. The clinical situation, the likely prognosis and the intensity of 
the symptoms will all influence decisions. Antidepressants are likely to offer better long 
term relief of anxiety. It is worth considering the full constellation of symptoms and trying to 
maximise benefit by employing medications that might assist other symptoms such as 
disturbed sleep and neuropathic pain. A trial of antidepressants for those with symptoms 
highly suggestive of a major depressive disorder should always be considered early. Choice 
about individual medicines will be guided by prescriber experience, confidence, route of 
administration, likely prognosis and assessment of possible side-effects and their likely 
impact on the person’s quality of life. 
 
And it can be argued that for the management of pain, most clinicians would initiate 
therapies even if there is incomplete understanding of the full aetiology of the 
pathophysiology of the symptom. For psychological symptoms it may be equally reasonable 
to commence interventions to assist in ameliorating the symptom, even in the absence of a 
full and clear diagnosis. The best way to support someone with a major psychological issue 
is to provide a coordinated interdisciplinary approach that is provided with professionals 
with different skills, working together to form a cohesive and consistent framework for the 
person and their family. 
 
What does it all mean? 
To be distressed and immobilised by emotion is not normal. Depression is not a normal part 
of dying. One must not ignore or avoid discussing these important issues, but help people to 
explore, if they wish, the meaning of what is happening and to assist in formulating a plan of 
support and intervention. To feel abandoned in such a situation would be unthinkable. 
 
The management of psychological issues particularly for people facing the likely end of their 
life is complex. It may be quite daunting. But this should not allow any to avoid assessing 
and commencing a therapeutic plan – be they inexperienced or experienced clinicians. 
Consider what resources are available within your network to provide advice and consider 
what further assessment and interventions might be available to assist you and your 
patients. 
 
It is important to try to provide continuity of care and emotional support, to understand the 
patient's concerns and needs and those of their family. There should be discussion about 
the nature of psychological issues and conditions, explanation of common somatic 
symptoms and a plan for intervention and support. Medications are important but not the 
only “answer.” Adverse effects on cognition, alertness, possibly mood and behaviour should 
be assessed. Anti-depressants may assist both anxiety and depression, with or without 
judicious, short-term benzodiazepine use. If they are likely to provide benefit, then 
prescription is better earlier rather than later. 
 
The burden on the carer, both professional and personal, in such situations should not be 
under-estimated. Those providing personal care are likely to require extra support as well. 
Clinicians should not under-estimate their own personal cost of supporting patients in these 
circumstances. The support of a team is useful and remembering to access the strategies for 
personal well-being is vital. 
 
“Slowly, I learn about the importance of powerlessness. I experience it in my own life and live 
with it in my work. The secret is not to be afraid of it – not to run away. The dying know we 
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